Immunoprecise Free Cash Flow vs Enterprise Value Analysis

IPA
 Stock
  

USD 3.80  0.04  1.04%   

Immunoprecise Antibodies financial indicator trend analysis is infinitely more than just investigating Immunoprecise Antibodies recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Immunoprecise Antibodies is a good investment. Please check the relationship between Immunoprecise Antibodies Free Cash Flow and its Enterprise Value accounts. Please see Risk vs Return Analysis.

Free Cash Flow vs Enterprise Value

Free Cash Flow vs Enterprise Value Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Immunoprecise Antibodies Free Cash Flow account and Enterprise Value. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Immunoprecise Antibodies' Free Cash Flow and Enterprise Value is -0.51. Overlapping area represents the amount of variation of Free Cash Flow that can explain the historical movement of Enterprise Value in the same time period over historical financial statements of Immunoprecise Antibodies, assuming nothing else is changed. The correlation between historical values of Immunoprecise Antibodies' Free Cash Flow and Enterprise Value is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Free Cash Flow of Immunoprecise Antibodies are associated (or correlated) with its Enterprise Value. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Enterprise Value has no effect on the direction of Free Cash Flow i.e., Immunoprecise Antibodies' Free Cash Flow and Enterprise Value go up and down completely randomly.

Correlation Coefficient

-0.51
Relationship DirectionNegative 
Relationship StrengthVery Weak

Free Cash Flow

Free Cash Flow is a measure of financial performance calculated as Net Cash Flow from Operations minus Capital Expenditure.

Enterprise Value

Enterprise Value (or EV) is usually referred to as Immunoprecise Antibodies theoretical takeover price. In the event of an acquisition, an acquirer would have to take on Immunoprecise Antibodies debt, but would also pocket its cash. Enterprise Value is more accurate representation of Immunoprecise Antibodies value than its market capitalization because it takes into account all of Immunoprecise Antibodies existing debt. Enterprise value is a measure of the value of a business as a whole; calculated as Market Capitalization plus Total Debt USD minus Cash and Equivalents USD.
Most indicators from Immunoprecise Antibodies fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Immunoprecise Antibodies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Please see Risk vs Return Analysis.The current year Issuance Purchase of Equity Shares is expected to grow to about 54.8 M, whereas Selling General and Administrative Expense is forecasted to decline to about 8.7 M.
 2019 2020 2021 2022 (projected)
Interest Expense537 K517 K594.55 K596.14 K
Gross Profit8.03 M11.54 M13.27 M11.78 M

Immunoprecise Antibodies fundamental ratios Correlations

0.98-0.960.980.58-0.990.920.651.0-0.960.990.820.82-0.7-0.960.821.00.930.851.0-0.55
0.98-0.971.00.62-1.00.90.680.98-0.960.990.840.84-0.7-0.950.840.980.930.850.98-0.59
-0.96-0.97-0.97-0.70.96-0.91-0.73-0.950.97-0.99-0.9-0.90.680.92-0.89-0.98-0.94-0.89-0.960.68
0.981.0-0.970.6-1.00.890.650.98-0.950.990.820.82-0.72-0.960.820.980.920.840.98-0.56
0.580.62-0.70.6-0.60.840.990.55-0.780.640.940.940.04-0.380.940.660.830.920.6-1.0
-0.99-1.00.96-1.0-0.6-0.91-0.66-0.990.96-0.99-0.82-0.820.690.95-0.82-0.99-0.93-0.85-0.990.56
0.920.9-0.910.890.84-0.910.90.9-0.990.930.950.95-0.37-0.770.960.951.00.980.92-0.82
0.650.68-0.730.650.99-0.660.90.63-0.840.70.960.960.0-0.440.960.720.880.960.67-0.98
1.00.98-0.950.980.55-0.990.90.63-0.950.990.790.79-0.72-0.960.790.990.920.831.0-0.52
-0.96-0.960.97-0.95-0.780.96-0.99-0.84-0.95-0.97-0.94-0.940.520.86-0.94-0.98-0.99-0.96-0.970.76
0.990.99-0.990.990.64-0.990.930.70.99-0.970.860.86-0.69-0.950.861.00.950.870.99-0.61
0.820.84-0.90.820.94-0.820.950.960.79-0.940.861.0-0.29-0.661.00.870.960.990.82-0.93
0.820.84-0.90.820.94-0.820.950.960.79-0.940.861.0-0.29-0.661.00.870.960.990.82-0.93
-0.7-0.70.68-0.720.040.69-0.370.0-0.720.52-0.69-0.29-0.290.88-0.28-0.65-0.43-0.27-0.69-0.06
-0.96-0.950.92-0.96-0.380.95-0.77-0.44-0.960.86-0.95-0.66-0.660.88-0.66-0.93-0.8-0.68-0.950.35
0.820.84-0.890.820.94-0.820.960.960.79-0.940.861.01.0-0.28-0.660.870.960.990.83-0.93
1.00.98-0.980.980.66-0.990.950.720.99-0.981.00.870.87-0.65-0.930.870.960.891.0-0.63
0.930.93-0.940.920.83-0.931.00.880.92-0.990.950.960.96-0.43-0.80.960.960.980.94-0.81
0.850.85-0.890.840.92-0.850.980.960.83-0.960.870.990.99-0.27-0.680.990.890.980.86-0.9
1.00.98-0.960.980.6-0.990.920.671.0-0.970.990.820.82-0.69-0.950.831.00.940.86-0.57
-0.55-0.590.68-0.56-1.00.56-0.82-0.98-0.520.76-0.61-0.93-0.93-0.060.35-0.93-0.63-0.81-0.9-0.57
Click cells to compare fundamentals

Immunoprecise Antibodies Account Relationship Matchups

Be your own money manager

Our tools can tell you how much better you can do entering a position in Immunoprecise Antibodies without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Crypto Correlations Now

   

Crypto Correlations

Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Immunoprecise Antibodies using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Risk vs Return Analysis. Note that the Immunoprecise Antibodies information on this page should be used as a complementary analysis to other Immunoprecise Antibodies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Complementary Tools for Immunoprecise Stock analysis

When running Immunoprecise Antibodies price analysis, check to measure Immunoprecise Antibodies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunoprecise Antibodies is operating at the current time. Most of Immunoprecise Antibodies' value examination focuses on studying past and present price action to predict the probability of Immunoprecise Antibodies' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Immunoprecise Antibodies' price. Additionally, you may evaluate how the addition of Immunoprecise Antibodies to your portfolios can decrease your overall portfolio volatility.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Is Immunoprecise Antibodies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunoprecise Antibodies. If investors know Immunoprecise will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunoprecise Antibodies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
90.4 M
Quarterly Revenue Growth YOY
0.066
Return On Assets
-0.19
Return On Equity
-0.43
The market value of Immunoprecise Antibodies is measured differently than its book value, which is the value of Immunoprecise that is recorded on the company's balance sheet. Investors also form their own opinion of Immunoprecise Antibodies' value that differs from its market value or its book value, called intrinsic value, which is Immunoprecise Antibodies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunoprecise Antibodies' market value can be influenced by many factors that don't directly affect Immunoprecise Antibodies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunoprecise Antibodies' value and its price as these two are different measures arrived at by different means. Investors typically determine Immunoprecise Antibodies value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunoprecise Antibodies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.